
The film follows a pioneering team of scientists and psychotherapists, led by Professor David Nutt, Dr Robin Carhart-Harris and Dr Rosalind Watts, as they compare the effects of psilocybin (the active ingredient of magic mushrooms) with an antidepressant (an SSRI called escitalopram) on a small group of participants with clinical depression. This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression.
Platform catalog indices and licensed providers for The Psychedelic Drug Trial.
Slow-Burn Atmospheric
7 / 10
Resonant Resolution
Cinematic Narrative
Calculated narrative telemetry highlights notable thematic precision within Documentary. With an established critical baseline of 7.0/10, the plot emphasizes slow-burn atmospheric pacing paired with an ending characterized by resonant resolution.
Low
Engagement barrierStandard Rhythmic Build
Story velocityHigh (Layered Nuances)
Hidden layers"Maintain active attention during the pivotal turning points. The narrative progression hinges on subtle thematic cues established in the first two acts before converging in the climax."
Contains complete plot revelations, climax analysis, and hidden clues for The Psychedelic Drug Trial. Proceed only if you have watched the finale.
Protect your online privacy and streaming security across devices.
Regional rights and catalog availability are subject to change by respective license holders. Affiliate links may provide commission to MOVIEINT.